Introducing pioneering strategies to drive human healthcare through the development of accurate, robust diagnostics and natural alleviation of chronic, cellular oxidative stress.
To identify tissue-specific diagnostic biomarkers of oxidative stress and implement natural, prophylactic solutions before disease becomes manifest.
To understand the biomolecular role of antioxidants and their synergistic action in maintaining cell homeostasis: a critical step for normal tissue function, and the support of cardiovascular, metabolic, neurological and reproductive health.
To apply the principles of drug design and delivery toward the development of comprehensively proven, safe and efficacious antioxidant formulations to restore a normal redox balance and support healthy cellular structure and function.
To maintain and develop strong academic research collaborations with pioneering departments across the world. Where possible, CellOxess endeavors to generate robust pre-clinical and/or clinical evidence to support its products.
WE ARE FIRMLY COMMITTED
MEET THE TEAM
President & CEO USA
PARVIZ GHARAGOZLOO PhD
Dr. Gharagozloo is the founder of CellOxess LLC and currently serves as its president and Chief Executive Officer. He has over 25 years of experience in Organic and Medicinal Chemistry gained in academia, tech transfer, biotech and pharmaceutical companies in the UK and USA. Prior to CellOxess, he led a group of medicinal chemists at Purdue Pharma in Cranbury, NJ targeting receptors, enzymes and ion-channels for the discovery of novel analgesics. Before joining Purdue in 2000, Dr. Gharagozloo was as the head of medicinal chemistry at Napp pharmaceuticals, a pain specializing company in Cambridge, UK where he led multiple research programs in drug discovery and served on the board of directors. He started his professional research career back in 1990 at the Medical Research Council Technology Center at Mill Hill in London, UK, where he spent 3 years as a postdoc and a further 5 years as a senior scientist and later as the head of medicinal chemistry department. He received his honors BSc degree in Chemistry and PhD in Medicinal chemistry in 1990 at University College London, UK. Dr. Gharagozloo has published extensively in the fields of organic and medicinal chemistry. His work is recognized by a number of international patents and he is the sole inventor of Fertilix.
PhD, ScD, FAHMS,
Chief Scientific Officer Australia
PRO VICE CHANCELLOR HEALTH & MEDICINE, LAUREATE PROFESSOR BIOLOGICAL SCIENCES, CO-DIRECTOR, PRIORITY RESEARCH CENTRE REPRODUCTIVE SCIENCE UNIVERSITY OF NEWCASTLE, NSW.
Laureate Professor Aitken’s research career began with a PhD in reproductive biology from the University of Cambridge. Following post-doctoral positions at the Institute of Animal Genetics, University of Edinburgh and the University of Bordeaux, he joined the World Health Organization in Geneva, where he managed two WHO task forces within the Human Reproduction Unit. In 1977, he joined the Medical Research Council’s Reproductive Biology Unit, University of Edinburgh, to establish a research group in gamete biology with clinical outreach into male infertility. In 1992, John was awarded an Honorary Professorship within the Faculty of Medicine of Edinburgh University and in 1998 he received a ScD degree from the University of Cambridge in recognition of his research contributions to gamete biology. John has published over 500 research articles, given more than 300 invited lectures and filed 12 patents. He has been elected a Fellow of both the Royal Society of Edinburgh and the Australian Academy of Science, was named as the New South Wales Scientist-of-the-Year in 2012, and 2016 recipient of the prestigious Carl G Hartman award. John Aitken is on the Editorial Boards of 8 journals at the present time. His work has been featured on television [Horizon, Tomorrow’s world, Beyond 2000, Catalyst (2x)], radio (Capital radio, SBS radio, ABC national and local radio as well as the BBC’s Cruicible, Science Now and Medicine Now) and printed media including feature articles in the New Scientist, Nature and the Australian.
Vice President, Finance USA
Ken Curcio joined Celloxess in May of 2014. He has over 35 years of experience in the fields of Accounting and Finance. He has spent over 14 years as the Chief Financial Officer at several diverse organizations, and 8 years in public accounting, most recently as a partner with Diversified Accounting Solutions, LLC. His experience includes retail, wholesale, fleet leasing and rental, manufacturing, distribution and non-profit. Ken has provided litigation support and expert testimony in legal cases requiring jury trials. He has particular strengths in budgeting, forecasting, projecting and managing cash flow and financing as these skills relate to small businesses and start-up organizations. He has a proven ability to guide small companies and start-ups to the next level.
Scientific / Medical Advisory Board
DIRECTOR ANDROSCIENCE, SCIENCE & INNOVATION CENTER IN ANDROLOGY; ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF SAO PAULO MEDICAL SCHOOL; SAO PAULO, BRAZIL.
Professor Jorge Hallak currently serves as an acting Urologist and Associate Professor of Medicine and Coordinator of the Reproductive Toxicology Unit, Department of Pathology at the University of Sao Paulo Medical School, as well as the Technical and Scientific Director of Androscience – Science and Innovation Center in Andrology in Sao Paulo, Brazil. Prof. Hallak’s career began with a medical degree at the University of Sao Paulo, with specializations in surgery and urology. In 1998, he completed a fellowship in Andrology and Male Infertility at the Cleveland Clinic, Department of Urology, with focus in microsurgery as well as sperm cryopreservation, physiology and biochemistry to then complete a PhD in Male Infertility in 1999. Jorge has since published over 70 research articles, 20 book chapters and delivered over 400 presentations at scientific conferences. Jorge has well regarded expertise in the anatomy of the male reproductive and sexual systems, physiology and biochemistry of human spermatozoa, advanced sperm function tests, as well as the influence of environmental pollution on male fertility. Prof. Hallak continues to be a regular contributing member to a number of international medical associations including, but not limited to, American Society of Andrology, American Urological Association, American Society for Reproductive Medicine, Society for the Study of Male Reproduction, International Society of Urology, and the International Society for the Study of the Aging Male. (ANEP).
Director, Business Development USA
Aron Moazamian obtained his Bachelor of Science degree with an Honors Research Thesis in Biology from The College of New Jersey and joined CellOxess in May 2013. After obtaining further training in molecular and cell biology in Professor Aitken’s laboratory in Australia, Aron applied his expertise towards the optimization and clinical development of a novel assay for the detection of DNA oxidation and diagnosis of cellular oxidative stress. Subsequently, he has been involved in all aspects of the business and demonstrated great acumen and drive in this area. Recognized as a highly gifted individual and leader by senior management, Aron has since represented CellOxess at trade shows, scientific conferences and plays a key role in daily domestic and global business operations. Aron’s combination of scientific and business skills uniquely position him as a direct link from CellOxess R&D advancing the company’s initiatives in preventative medicine by isolating areas of unmet clinical need, towards ultimately addressing them with current and future products.
Scientific Advisory Board FRANCE
VICE PRESIDENT UNIVERSITY CLERMONT AUVERGNE; DEPUTY DIRECTOR GReD LABORATORY (INSERM U1103-CNRS UMR6293, FACULTY OF MEDICINE); PROFESSOR, IMMUNOLOGY & REPRODUCTIVE BIOLOGY.
Professor Drevet's research focuses on the post-testicular stages of sperm maturation during their descent and storage in the epididymis. His main research topic concerns aspects of oxidative stress and its impact on sperm fertilization capacity, sperm nuclear structure integrity and potential transgenerational effects, both in natural reproduction and in assisted reproductive technologies (ART). Cholesterol homeostasis and immune control in the epididymis are other aspects of epididymal physiology on which his team is currently working at both the basic and clinical science levels. Joël Drevet is a member of the European Academy of Andrology (EAA), the European Society of Human Reproduction and Embryo (ESHRE), the North American Society for Studies on Reproduction (SSR) and the French Andrology Society (SALF), a daughter society of the International Society of Andrology (ISA). Joël is managing Editor of the journal BaCA (Basic & Clinical Andrology) the Journal of the French Andrology Society, associate Editor of the journal Asian Journal of Andrology, academic editor of the journal Oxidative Medicine & Cellular Longevity, associate editor of the journal Antioxidants and, academic editor of the journal PLoS ONE. In addition, Joël is currently a member of the review board of Andrology. In recent years, Prof. Drevet has been Associate Editor of Human Reproduction (2011-2016) and a member of the reviewing committee for the journal Biology of Reproduction (2013-2016). The Drevet research team has trained more than 18 doctoral students and published more than 110 articles (factor H:36 and citation index greater than 3900).
Scientific Advisory Board SPAIN
DEPARTMENT DIRECTOR ANIMAL REPRODUCTION, INIA-MADRID; LABORATORY DIRECTOR GAMETOGENESIS, EMBRYO DEVELOPMENT AND mRNA SPLICING, INIA-MADRID.
Dr. Alfonso Gutierrez-Adan obtained his PhD in Biological Sciences from University of Oviedo in Spain. He then moved to the USA to do his postdoctoral training at the Department of Animal Sciences, University of Davis, CA. In 1997 he returned to Madrid to the Department of Animal Reproduction at INIA as a research scientist. He is now the Head of the “Gametogenesis, embryo development and mRNA splicing” lab (https://laborepro.wixsite.com/gutierrez-adan) and Director of Department of Animal Reproduction, INIA, Madrid Spain. His research team is mainly interested in understanding the molecular events of early mammalian fertilization and embryonic development, and how the quality of gamete/embryos, and reproductive technologies contribute to the adult phenotype. He is a pioneer in the transcriptomic and epigenomic analysis of preimplantation embryos in animal models and farm animals. He has authored or contributed to more than 200 peer reviewed publications, and 40 international invited conferences.